The anticancer peptide LL-III alters the physico-chemical properties of a model tumor membrane promoting lipid bilayer permeabilization
Physical Chemistry Chemical Physics · 2023
DOI: 10.1039/d2cp03528f ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Chemistry Chemical Physics, 2023. Verfasst von Marco Campanile und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy. luigi.petraccone@unina.it. Hauptthemen laut MEDLINE: Lipid Bilayers, Liposomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
LL-III is an anticancer peptide and has the ability to translocate across tumor cell membranes, which indicates that its action mechanism could be non-membranolytic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy. luigi.petraccone@unina.it.
Zitieren
APA
Campanile, M., Oliva, R., D'Errico, G., Del Vecchio, P., & Petraccone, L. (2023). The anticancer peptide LL-III alters the physico-chemical properties of a model tumor membrane promoting lipid bilayer permeabilization. Physical Chemistry Chemical Physics. https://doi.org/10.1039/d2cp03528f
Vancouver
Campanile M, Oliva R, D'Errico G, Del Vecchio P, Petraccone L. The anticancer peptide LL-III alters the physico-chemical properties of a model tumor membrane promoting lipid bilayer permeabilization. Physical Chemistry Chemical Physics. 2023. doi:10.1039/d2cp03528f
BibTeX
@article{Campanile2023,
author = {Campanile, Marco and Oliva, Rosario and D'Errico, Gerardino and Del Vecchio, Pompea and Petraccone, Luigi},
title = {The anticancer peptide LL-III alters the physico-chemical properties of a model tumor membrane promoting lipid bilayer permeabilization},
journal = {Physical Chemistry Chemical Physics},
year = {2023},
doi = {10.1039/d2cp03528f}
}
EUVIMED